Filter
623
Filtered Results: 623
Text search:
molecular
markers
Featured
Recommendations
78
New Publications
123
Language
Document type
No document type
268
Studies & Reports
133
Guidelines
129
Manuals
44
Strategic & Response Plan
24
Training Material
11
Fact sheets
10
Situation Updates
3
Resource Platforms
1
Countries / Regions
India
52
Global
27
Latin America and the Carribbean
16
Kenya
15
Tanzania
14
Western and Central Europe
12
Africa
11
Ethiopia
10
South Africa
9
Nigeria
8
Eastern Europe
8
South–East Asia Region
7
Uganda
6
Sierra Leone
5
Zimbabwe
5
Philippines
5
Ukraine
4
Malawi
4
Asia
4
West and Central Africa
4
Western Pacific Region
4
East and Southern Africa
4
Indonesia
4
Nepal
3
Cameroon
3
Congo, Democratic Republic of
3
North America
3
Brazil
3
Myanmar / Burma
3
Pakistan
3
Ghana
2
Benin
2
Syria
2
Burkina Faso
2
Guinea
2
USA
2
Venezuela
2
Bangladesh
2
Zambia
2
Liberia
2
North Macedonia
1
Timor Leste/ East Timor
1
Thailand
1
Lesotho
1
China
1
Rwanda
1
Iran
1
Senegal
1
Afghanistan
1
Peru
1
Malaysia
1
Cambodia
1
Jordan
1
Germany
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Gabon
1
Japan
1
United Kingdom
1
Spain
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Vietnam
1
Sri Lanka
1
Namibia
1
Georgia
1
Angola
1
Chad
1
Somalia
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
170
Clinical Guidelines
94
Public Health
40
Pharmacy & Technologies
26
Key Resources
17
Women & Child Health
15
Capacity Building
3
Toolboxes
TB
79
AMR
63
COVID-19
60
HIV
39
Rapid Response
35
NTDs
34
Mental Health
33
Planetary Health
23
Malaria
20
NCDs
17
Ebola & Marburg
14
Pharmacy
13
Refugee
8
Specific Hazards
6
Global Health Education
6
Zika
5
Polio
5
Conflict
4
Disability
3
Cholera
3
Caregiver
3
Health Financing Toolbox
3
Natural Hazards
2
Social Ethics
1
This guidance is intended for use in developing standalone TB strategic plans, or TB interventions as part of multidisease or health sector plans. It describes key considerations and steps for strategic planning for TB in line with the World Health Organization’s End TB strategy, and the proposed ...
WHO needs US$2.54 billion to provide life-saving assistance to millions of people around the world facing health emergencies. WHO’s Health Emergency Appeal is a consolidation of WHO’s priorities and financial requirements for 2023 to carry out health interventions in emergency and humanitarian r...
Monitoring of implementation of collaborative TB/HIV activities and evaluation of impact is critically important. This requires efficient monitoring and evaluation system so as to establish accountability mechanisms between programmes, the population they serve, and donors. The Guide to monitoring a...
"The aim of this book remains as for the first edition, namely to provide an initial point of ready
reference for the identification of hazards and precautions for dangerous chemicals. It is targeted
not only at those in the chemical and process industries, but also anyone likely to work with
che...
This short paper aims to identify key evidence gaps in our knowledge of livestock- and fisheries-linked antimicrobial resistance in the developing world, and to document on-going or planned research initiatives on this topic by key stakeholders.
The antimicrobial resistant (AMR) infections in anima...
WHO Ghana 2022 annual report
recommended
“2022 was an eventful year for the WHO Country Office in Ghana,” says Dr Francis Kasolo, WHO Representative to Ghana.
In 2022, WHO Ghana collaborated with partners to deliver interventions in support of the Government of Ghana's health sector agenda to ensure healthy lives for all towards ach...
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...
The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools and mechanisms to support Member States and key stakeholders to mitigate and prevent biorisks and govern dual-u...
his guidance provides interim guidance for the integration of SARS-CoV-2 and influenza virologic and genomic surveillance, from sentinel site case enrolment and sampling to the eventual sharing of the virus sequence data, a process known as end-to-end surveillance. This guidance builds on experience...
Using the WHO model list of essential medicines to update a national essential medicines list
Since 1977, WHO has been working with countries to design the package of essential medicines as an integral component of treatment within the continuum of care, developing and disseminating the Model List ...
BMJ Global Health2020;5:e002914. doi:10.1136/bmjgh-2020-002914
The evidence produced in mathematical models plays a key role in shaping policy decisions in pandemics. A key question is therefore how well pandemic models relate to their implementation contexts. Drawing on the cases of Ebola and in...
This report presents an overview of the transition process in Azerbaijan, some sustainability aspects and challenges stemming from donor withdrawal from TB-related activities, along with recommendations on how to overcome transition-related difficulties and ensure sustainability.
WHO Technical Series 971
A Students' Toolkit.
How does the digital transformation of health care change the daily routine of a healthcare professional? Which knowledge and skills will healthcare professionals need? Are universities in Europe preparing their students well enough to work within a digitised health system?
Th...
The WHO operational handbook on tuberculosis: tuberculosis preventive treatment is the companion, implementation guide to the 2020 WHO guidelines on TB preventive treatment.[1] Just as these guidelines are the first to be released under the rubric of the WHO consolidated TB guidelines, this handbook...
